Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 株洲千金药业股份有限公司是一家主要研制、生产、销售中成药的公司,是全国中成药工业重点企业50强.产品有妇科千金片、舒筋风湿酒、补血益母颗粒等,主要产品妇科千金片是国家基本药物、国家中药保护品种和《国家基本医疗保险药品目录》中的甲类药品,该产品畅销全国绝大部分省市.其中片剂、胶囊剂、颗粒剂等生产线获GMP认证。 | ||||||||||||||||||||||||
Main Business | 主要从事中成药、化学药和女性卫生用品的研制、生产和销售以及药品的批发和零售业务 | ||||||||||||||||||||||||
Legal Representative | 蹇顺 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 朱溧 | ||||||||||||||||||||||||
Solicitors | 湖南启元律师事务所 | ||||||||||||||||||||||||
Auditors | 天职国际会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 0731-22496088 | ||||||||||||||||||||||||
Fax No | 0731-22496088 | ||||||||||||||||||||||||
Website | www.qjyy.com | ||||||||||||||||||||||||
qianjin@qjyy.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 12/03/2004 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 0.758 | ||||||||||||||||||||||||
DPS(RMB)* | ¥ 0.350 | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 5.571 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 5.390B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |